New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Experimental drug trial seeks to improve treatment for head and neck cancer

Experimental drug trial seeks to improve treatment for head and neck cancer

by Cancer Research UKCredit: Cancer Research UKA trial to test an experimental drug in patients with head and neck cancer launches in the UK today (Friday), through the Combinations Alliance – a
Oncology May 21,2024
Experimental drug trial seeks to improve treatment for head and neck cancer

Experimental drug trial seeks to improve treatment for head and neck cancer

by Cancer Research UKCredit: Cancer Research UKA trial to test an experimental drug in patients with head and neck cancer launches in the UK today (Friday), through the Combinations Alliance – a
Oncology May 21,2024
Study explores why patients skip appointments for suspected cancer

Study explores why patients skip appointments for suspected cancer

by Shelley Hughes,University of YorkCredit: CC0 Public DomainMen, the elderly and people from deprived areas are among the patients most likely to miss an urgent referral appointment for suspect
Oncology May 21,2024
Study explores why patients skip appointments for suspected cancer

Study explores why patients skip appointments for suspected cancer

by Shelley Hughes,University of YorkCredit: CC0 Public DomainMen, the elderly and people from deprived areas are among the patients most likely to miss an urgent referral appointment for suspect
Oncology May 21,2024
More aggressive treatment doesn't impact quality of life for metastatic colorectal cancer patients, says new study

More aggressive treatment doesn't impact quality of life for metastatic colorectal cancer patients, says new study

by National Comprehensive Cancer NetworkCredit: Unsplash/CC0 Public DomainNewresearchin the October 2023 issue ofJournal of the National Comprehensive Cancer Networkfinds that
Oncology May 21,2024
More aggressive treatment doesn't impact quality of life for metastatic colorectal cancer patients, says new study

More aggressive treatment doesn't impact quality of life for metastatic colorectal cancer patients, says new study

by National Comprehensive Cancer NetworkCredit: Unsplash/CC0 Public DomainNewresearchin the October 2023 issue ofJournal of the National Comprehensive Cancer Networkfinds that
Oncology May 21,2024
Study deciphers packaging of tumor 'cargo,' leading to better understanding of how cancers spread

Study deciphers packaging of tumor 'cargo,' leading to better understanding of how cancers spread

by Deanna Csomo Mccool,University of Notre DameCredit: Crislyn D’Souza-SchoreyResearchers at the University of Notre Dame have outlined the delivery mechanism tumor cells use to move nucleic aci
Oncology May 21,2024
Study deciphers packaging of tumor 'cargo,' leading to better understanding of how cancers spread

Study deciphers packaging of tumor 'cargo,' leading to better understanding of how cancers spread

by Deanna Csomo Mccool,University of Notre DameCredit: Crislyn D’Souza-SchoreyResearchers at the University of Notre Dame have outlined the delivery mechanism tumor cells use to move nucleic aci
Oncology May 21,2024
New study reveals an unexpected survival mechanism of a subset of cancer cells

New study reveals an unexpected survival mechanism of a subset of cancer cells

by Instituto de Medicina MolecularMetaphase chromosomes from ALT cancer cells (U2OS osteosarcoma cell line) depleted for FANCM. Telomeric DNA is in green, chromosomal DNA is in red. The arrowheads poi
Oncology May 21,2024
New study reveals an unexpected survival mechanism of a subset of cancer cells

New study reveals an unexpected survival mechanism of a subset of cancer cells

by Instituto de Medicina MolecularMetaphase chromosomes from ALT cancer cells (U2OS osteosarcoma cell line) depleted for FANCM. Telomeric DNA is in green, chromosomal DNA is in red. The arrowheads poi
Oncology May 21,2024
Poor oral health linked to a 75% increase in liver cancer risk, new study finds

Poor oral health linked to a 75% increase in liver cancer risk, new study finds

by SAGE PublicationsCredit: CC0 Public DomainThe study, by researchers at Queen's University Belfast, analysed a large cohort of over 469,000 people in the UK, investigated the association be
Oncology May 21,2024
Poor oral health linked to a 75% increase in liver cancer risk, new study finds

Poor oral health linked to a 75% increase in liver cancer risk, new study finds

by SAGE PublicationsCredit: CC0 Public DomainThe study, by researchers at Queen's University Belfast, analysed a large cohort of over 469,000 people in the UK, investigated the association be
Oncology May 21,2024
Familial breast cancer not only inherited genetically, finds new study

Familial breast cancer not only inherited genetically, finds new study

by University of MelbourneCredit: CC0 Public DomainMutations in known breast cancer genes such as BRCA1 and BRCA2 are identified in only approximately 20 per cent of women who are offered genetic
Oncology May 21,2024
Familial breast cancer not only inherited genetically, finds new study

Familial breast cancer not only inherited genetically, finds new study

by University of MelbourneCredit: CC0 Public DomainMutations in known breast cancer genes such as BRCA1 and BRCA2 are identified in only approximately 20 per cent of women who are offered genetic
Oncology May 21,2024
New study estimates preventable cancer burden linked to poor diet in the US

New study estimates preventable cancer burden linked to poor diet in the US

by Tufts UniversityA new study estimates that 5.2 percent of new invasive cancer cases reported in 2015 are associated with poor diets. Credit: Nako Kobayashi/Tufts UniversityA new modeling study
Oncology May 21,2024
New study estimates preventable cancer burden linked to poor diet in the US

New study estimates preventable cancer burden linked to poor diet in the US

by Tufts UniversityA new study estimates that 5.2 percent of new invasive cancer cases reported in 2015 are associated with poor diets. Credit: Nako Kobayashi/Tufts UniversityA new modeling study
Oncology May 21,2024
Some cervical cancer screening strategies more cost-effective

Some cervical cancer screening strategies more cost-effective

(HealthDay)—A cervical cancer screening strategy that involves cytologic testing every three years from ages 21 to 29 years and then continuing cytologic testing or switching to low-cost high-risk hum
Oncology May 21,2024
Some cervical cancer screening strategies more cost-effective

Some cervical cancer screening strategies more cost-effective

(HealthDay)—A cervical cancer screening strategy that involves cytologic testing every three years from ages 21 to 29 years and then continuing cytologic testing or switching to low-cost high-risk hum
Oncology May 21,2024
Study may explain why once-promising cancer drugs failed

Study may explain why once-promising cancer drugs failed

by Duke UniversityInvading cells (green) in the lab wormC. elegans(purple) can change their tactics to get around cancer drugs called MMP inhibitors and trespass into other tissues. T
Oncology May 21,2024
Study may explain why once-promising cancer drugs failed

Study may explain why once-promising cancer drugs failed

by Duke UniversityInvading cells (green) in the lab wormC. elegans(purple) can change their tactics to get around cancer drugs called MMP inhibitors and trespass into other tissues. T
Oncology May 21,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com